Maravai LifeSciences Holdings, Inc. (MRVI)
Largest Insider Buys in Sector
MRVI Stock Price History Chart
MRVI Stock Performance
About Maravai LifeSciences Holdings, Inc.
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of …
Insider Activity of Maravai LifeSciences Holdings, Inc.
Over the last 12 months, insiders at Maravai LifeSciences Holdings, Inc. have bought $1.09M and sold $97.57M worth of Maravai LifeSciences Holdings, Inc. stock.
On average, over the past 5 years, insiders at Maravai LifeSciences Holdings, Inc. have bought $2.9M and sold $97.57M worth of stock each year.
Highest buying activity among insiders over the last 12 months: HULL CARL (See Remarks) — $987,000. DeFord John A (director) — $100,625.
The last purchase of 17,500 shares for transaction amount of $100,625 was made by DeFord John A (director) on 2024‑11‑12.
List of Insider Buy and Sell Transactions, Maravai LifeSciences Holdings, Inc.
| 2024-11-12 | director | 17,500 0.0126% | $5.75 | $100,625 | -12.98% | |||
| 2024-11-11 | See Remarks | 175,000 0.1231% | $5.64 | $987,000 | -11.94% | |||
| 2024-05-28 | Sale | 9.94M 6.814% | $9.81 | $97.57M | -21.85% | |||
| 2020-11-25 | Chief Executive Officer | 35,000 0.0865% | $26.94 | $942,900 | +39.24% | |||
| 2020-11-24 | director | 50,000 0.127% | $27.00 | $1.35M | +42.73% | |||
| 2020-11-24 | director | 20,000 0.0508% | $27.00 | $540,000 | +42.73% | |||
| 2020-11-24 | director | 18,000 0.0457% | $27.00 | $486,000 | +42.73% | |||
| 2020-11-24 | director | 15,000 0.0381% | $27.00 | $405,000 | +42.73% | |||
| 2020-11-24 | director | 10,000 0.0254% | $27.00 | $270,000 | +42.73% | |||
| 2020-11-24 | See Remarks | 18,888 0.048% | $27.00 | $509,976 | +42.73% | |||
| 2020-11-24 | General Counsel | 7,500 0.019% | $27.00 | $202,500 | +42.73% |
Insider Historical Profitability
| HULL CARL | See Remarks | 175000 0.1234% | $5.22 | 2 | 0 | +39.24% |
| DeFord John A | director | 70046 0.0494% | $5.22 | 1 | 0 | |
| Hopfield Jessica | director | 61852 0.0436% | $5.22 | 1 | 0 | +42.73% |
| GRAY SUSANNAH | director | 31852 0.0225% | $5.22 | 1 | 0 | +42.73% |
| PRAHALAD MURALI | director | 29852 0.021% | $5.22 | 1 | 0 | +42.73% |
Institutional Investor Ownership
| GTCR | $187.97M | 8.61 | 21.68M | 0% | +$0 | 15.96 | |
| 12 West Capital Management LP | $114.47M | 5.24 | 13.2M | +13.79% | +$13.87M | 10.44 | |
| The Vanguard Group | $87.03M | 3.99 | 10.04M | +0.34% | +$296,791.44 | <0.01 | |
| Braidwell Lp | $62.61M | 2.87 | 7.22M | +43.27% | +$18.91M | 3.55 | |
| BlackRock | $55.61M | 2.55 | 6.41M | -1.03% | -$581,271.48 | <0.01 |